EP2968302
Samsetning andveiruefna með beinni virkni og ríbavíríns til meðhöndlunar á sjúklingum með lifrarbólgu C
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
14.3.2014EP published:
6.9.2017EP application number:
14725812.3
EP translation filed:
6.12.2017Grant published:
15.1.2018EPO information:
European Patent Register
Max expiry date:
13.3.2034Expiry date:
13.3.2021
Title:
COMBINATION OF DIRECT ACTING ANTIVIRAL AGENTS AND RIBAVIRIN FOR TREATING HCV PATIENTS
Timeline
Today
14.3.2014EP application
6.9.2017EP Publication
6.12.2017Translation submitted
15.1.2018Registration published
13.3.2021Expires
Owner
Name:
AbbVie Inc.Address:
1 North Waukegan Road, 60064, North Chicago, IL, US
Inventor
Name:
BERNSTEIN, Barry M.Address:
Mequon, Wisconsin, US
Name:
DUTTA, SandeepAddress:
Lincolnshire, Illinois, US
Name:
LIU, WeiAddress:
Mundelein, Illinois, US
Name:
PODSADECKI, Thomas J.Address:
Northbrook, Illinois, US
Name:
CAMPBELL, Andrew L.Address:
Lake Forest, Illinois, US
Name:
MENON, Rajeev M.Address:
Buffalo Grove, Illinois, US
Name:
LIN, Chih-WeiAddress:
Vernon Hills, Illinois, US
Name:
WANG, TianliAddress:
Lake Bluff, Illinois, US
Name:
AWNI, Walid M.Address:
Green Oaks, Illinois, US
Name:
MENSING, SvenAddress:
Mannheim, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361783437 PDate:
14.3.2013Country:
US
Classification
Categories:
A61K 31/454, A61K 31/4985, A61K 31/7056, A61P 31/22
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 12.1.2018
Expires: 13.3.2019
Payer: Örn Þór, slf.
Number: 6
Paid: 14.2.2019
Expires: 13.3.2020
Payer: Örn Þór, slf.
Number: 7
Paid: 14.2.2020
Expires: 13.3.2021
Payer: Örn Þór slf.